Status | Study |
Recruiting |
Study Name: Newborn Screening for Adrenoleukodystrophy Condition: Adrenoleukodystrophy Date: 2016-10-31 Interventions: Procedure: newborns testing for ALD Routine newborn screening dried blood spots sample is used to test i |
Not yet recruiting |
Study Name: Early Diagnosis Of Childhood Cerebral ALD Condition: Adrenoleukodystrophy Date: 2016-10-25 |
Completed |
Study Name: THIN Database Study: Resource Use and Outcomes in Patients With Adrenal Insufficiency Prescribed Hydrocortisone: Immediate, or Modified Release, or Prednisolone Condition: Adrenal Insufficiency Date: 2016-10-20 Interventions: Other: Corticosteroid medication Patients will be grouped into Cohort 1 (IR hydrocortisone), cohort 2 (I |
Recruiting |
Study Name: Impact of Pre-operative Steroids on Adrenal Insufficiency Condition: Adrenal Insufficiency Neonatal Date: 2016-10-14 Interventions: Other: No pre-operative steroids Due to new information provide from previous studies at our center the |
Recruiting |
Study Name: Mass Spectrometry Based Cutoffs for Cortisol After Stimulation Tests Condition: Adrenal Insufficiency Date: 2016-06-14 Interventions: Drug: Synachten To stimulate the adrenals to increase the cortisol Production as much as possible |
Recruiting |
Study Name: Evaluation of Children With Endocrine and Metabolic-Related Conditions Condition: Adrenal Insufficiency Growth Disorder Date: 2016-05-11 |
Completed |
Study Name: Treatment of Adrenal Insufficiency in Children Condition: Adrenal Insufficiency Date: 2016-03-16 Interventions: Drug: Infacort® dry granule formulation of hydrocortisone |
Recruiting |
Study Name: Extension Study for Patients Entered Into Study Infacort 003 Condition: Adrenal Insufficiency Date: 2016-03-16 Interventions: Drug: Infacort® Infacort® is a dry granule formulation of hydrocortisone stored in capsules th |
Recruiting |
Study Name: Hydrocortisone Treatment In Systemic Low Blood Pressure During Hypothermia in Asphyxiated Newborns Condition: Hypoxic-Ischemic Encephalopathy Asphyxia Date: 2016-02-24 Interventions: Drug: Hydrocortisone 4 * 0,5 m |
Enrolling by invitation |
Study Name: Long-term Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product Condition: Cerebral Adrenoleukodystrophy (CALD) Adrenoleukodystrophy (ALD) Date: 2016-02-17 Interventions: Other: Safety and efficacy assessments Vector copy number (VCN) measurement, safety evaluations, disease |